lobbying_activities: 2458625

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2458625	6d50b898-5265-4457-9302-c6012138cdb8	2T	ALLERGAN USA, INC.	63837	ALLERGAN USA, INC.	2020	second_quarter	HCR	Proposals encouraging research and development and manufacturing of potentially life-saving treatments and ensuring patient access to improve quality of life; supporting protections for patients from illegal and inappropriate exposure to counterfeit and diverted medicines; promoting new therapeutic approaches to gene therapy and tissue replacement toward unmet medical needs; education regarding emerging health care concerns surrounding rare and undiagnosed diseases; support for providing incentives to encourage development of novel anti-infective treatments to counter microbial resistant diseases; support for protecting research and development for novel diagnostics, treatments and vaccines.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office		230000	0	1	2020-05-13T14:51:32.380000-04:00